Product NDC: | 0085-0942 |
Proprietary Name: | CELESTONE |
Non Proprietary Name: | Betamethasone |
Active Ingredient(s): | .6 mg/5mL & nbsp; Betamethasone |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0085-0942 |
Labeler Name: | Schering Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA014215 |
Marketing Category: | NDA |
Start Marketing Date: | 20110818 |
Package NDC: | 0085-0942-05 |
Package Description: | 1 BOTTLE in 1 CARTON (0085-0942-05) > 118 mL in 1 BOTTLE |
NDC Code | 0085-0942-05 |
Proprietary Name | CELESTONE |
Package Description | 1 BOTTLE in 1 CARTON (0085-0942-05) > 118 mL in 1 BOTTLE |
Product NDC | 0085-0942 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Betamethasone |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20110818 |
Marketing Category Name | NDA |
Labeler Name | Schering Corporation |
Substance Name | BETAMETHASONE |
Strength Number | .6 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |